nicardipine has been researched along with HELLP Syndrome in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
HELLP Syndrome: A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " She developed a prolonged and deep neuromuscular blockade, which was antagonized three hours later with neostigmine." | 3.83 | Prolonged neuromuscular block in a preeclamptic patient induced by magnesium sulfate. ( Berdai, MA; Harandou, M; Labib, S, 2016) |
| "Nicardipine infusion was started for temporizing management of pre-eclampsia at a dosage of 3 mg/h and was subsequently titrated according to blood pressure." | 3.73 | Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients. ( Bartels, PA; Bijvank, BN; Hanff, LM; Roofthooft, DW; Steegers, EA; Visser, W; Vulto, AG, 2005) |
| " It is suggested that a suitable dosage of fentanyl is effective without causing serious side effects for neonate." | 1.29 | [Anesthesia for a patient with HELLP syndrome]. ( Sakio, H; Satoh, T; Takahashi, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grandjean, B | 1 |
| Guerci, P | 1 |
| Raft, J | 1 |
| Fuchs-Buder, T | 1 |
| Bouaziz, H | 1 |
| Berdai, MA | 1 |
| Labib, S | 1 |
| Harandou, M | 1 |
| Hanff, LM | 1 |
| Vulto, AG | 1 |
| Bartels, PA | 1 |
| Roofthooft, DW | 1 |
| Bijvank, BN | 1 |
| Steegers, EA | 1 |
| Visser, W | 1 |
| Takahashi, H | 1 |
| Satoh, T | 1 |
| Sakio, H | 1 |
4 other studies available for nicardipine and HELLP Syndrome
| Article | Year |
|---|---|
[Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
Topics: Abortion, Therapeutic; Acetylcholine; Adult; Androstanols; Anesthesia, General; Calcium Signaling; E | 2013 |
Prolonged neuromuscular block in a preeclamptic patient induced by magnesium sulfate.
Topics: Adult; Anesthesia, General; Cesarean Section; Female; HELLP Syndrome; Humans; Magnesium Sulfate; Neo | 2016 |
Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Female; Fetus; | 2005 |
[Anesthesia for a patient with HELLP syndrome].
Topics: Adult; Alprostadil; Anesthesia, General; Anesthesia, Obstetrical; Cesarean Section; Female; Fentanyl | 1996 |